Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Mol Cell Biol ; 3(12): 2287-97, 1983 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6197627

RESUMEN

Transient exposure of mycelia from Aspergillus niger and Aspergillus nidulans to the cytidine analog 5-azacytidine, leading to no more than 0.3 to 0.5% substitution for cytosine by 5-azacytosine in A. nidulans DNA, resulted in the conversion of a high fraction of the cell population (more than 20%) to a mitotically and meiotically stable "fluffy" developmental phenotype. The phenotypic variants are characterized by the developmentally timed production of a profuse fluffy network of undifferentiated aerial hyphae that seem to escape signals governing vegetative growth. Genetic analysis with six different fluffy clones reveals that this trait is not cytoplasmically coded, is recessive in heterozygous diploids but codominant in heterokaryons, and exhibits a 1:1 Mendelian segregation pattern upon sexual sporulation of heterozygous diploids. Complementation and mitotic haploidization studies indicated that all variants are affected in the same gene, which can be tentatively located on chromosome VIII of A. nidulans. Molecular analysis to search for modified bases showed that DNA methylation is negligible in in both A. niger and A. nidulans and that no differences could be detected among DNAs from wild-type cells, fluffy clones, or mycelia exposed to 5-azacytidine. It thus appears that high-frequency conversion of fungal mycelia to a stable, variant developmental phenotype by 5-azacytidine is the result of some kind of target action on a single nuclear gene and that this conversion can occur in organisms virtually devoid of DNA methylation.


Asunto(s)
Aspergillus nidulans/genética , Aspergillus niger/genética , Azacitidina/farmacología , Genes Fúngicos/efectos de los fármacos , Aspergillus nidulans/efectos de los fármacos , Aspergillus nidulans/crecimiento & desarrollo , Aspergillus niger/efectos de los fármacos , Aspergillus niger/crecimiento & desarrollo , ADN de Hongos/metabolismo , Genotipo , Cinética , Metilación , Fenotipo , Especificidad de la Especie
2.
J Antibiot (Tokyo) ; 32(6): 600-6, 1979 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-112091

RESUMEN

Mutants have been isolated in which phosphate does not inhibit the biosynthesis of candicidin. At high phosphate concentrations, candicidin production by phosphate-deregulated mutants is still inhibited, but to a lesser extent than in the wild type. Some of these mutants are higher candicidin producers than the wild type, not only in phosphate-supplemented medium but also in non-supplemented production medium. The high candicidin production by these mutants is due to (1) a high specific rate of candicidin biosynthesis and (2) an extended production phase. None of the phosphate-deregulated mutants in which uptake of [32P]phosphate was measured was a phosphate-permeability mutant.


Asunto(s)
Antifúngicos/biosíntesis , Candicidina/biosíntesis , Fosfatos/farmacología , Streptomyces griseus/genética , Cinética , Mutación , Fosfatos/metabolismo , Streptomyces griseus/efectos de los fármacos , Streptomyces griseus/metabolismo
3.
J Bacteriol ; 133(2): 542-8, 1978 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-415042

RESUMEN

The filamentous fungus Penicillium italicum produced a certain level of beta-1,3-glucanase during active growth in a glucose-supplemented medium; however, at a low glucose concentration (2 to 10 mM), derepression took place and the specific activity of the enzyme increased significantly. Derepressed cells (incubated in a glucose-limited medium) accumulated a capacity for the synthesis of beta-1,3-glucanase, which led to a subsequent increase in the specific activity even when the cells were transferred to a medium with an excess of glucose (180 mM). Two protein synthesis inhibitors, cycloheximide and trichodermin, immediately stopped the increase in specific activity when added to derepressed cells. On the other hand, 8-hydroxyquinoline, an RNA a synthesis inhibitor, acted differently, since it permitted the specific activity to increase for some time after being added to depressed cells. Moreover, the concentration of glucose did not affect the 8-hydroxyquinoline-insensitive synthesis of beta-1,3-glucanase. It is concluded that the glucose repression effect on beta-1,3-glucanase production must be exerted at a pretranslational level that could be either mRNA synthesis or some stage of the process involved in its maturation or stabilization.


Asunto(s)
Penicillium/enzimología , Cicloheximida/farmacología , Represión Enzimática , Proteínas Fúngicas/biosíntesis , Glucano Endo-1,3-beta-D-Glucosidasa/metabolismo , Glucosa/farmacología , Oxiquinolina/farmacología , ARN/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA